Medicinova Inc (MNOV) Institutional Holdings & 13F Data (Q2 2026)

MNOV ranks #7466 out of 37527 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

30 institutions disclose a position in MNOV, but none treat it as a major bet — even Essex Woodlands Management, Inc., its most concentrated holder, allocates just 0.6% of its own portfolio to it.

BlackRock has added to its MNOV position for two straight quarters, increasing it by $69.3K to reach $992.8K today.

Jane Street Group, LLC has trimmed its MNOV position for two straight quarters, cutting it by $192.8K while still holding $20.9K.

MNOV reported a net loss of $10.8M over the trailing twelve months.

• Not yet profitable — net loss of $10.8M over the trailing twelve months
• Revenue declined 18.9% year over year
• Net income improved year over year, from -$11.8M to -$10.8M
• Operating cash flow was negative, using $9.8M in cash
• Current ratio of 8.16x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.10x equity — within a conventional range